Immunotherapy for non–small cell lung cancer: A therapy for all stages? Journal Article
| Authors: | Aly, R. G.; Vaghjiani, R. G.; Adusumilli, P. S. |
| Article Title: | Immunotherapy for non–small cell lung cancer: A therapy for all stages? |
| Keywords: | immunohistochemistry; cancer survival; protein expression; treatment outcome; treatment response; overall survival; drug tolerability; cancer recurrence; cancer staging; cd3 antigen; cancer immunotherapy; dendritic cell; editorial; docetaxel; cancer cell; cytotoxic t lymphocyte; clinical effectiveness; neoadjuvant chemotherapy; macrophage; programmed death 1 ligand 1; programmed death 1 receptor; non small cell lung cancer; tumor microenvironment; interleukin 7 receptor; nivolumab; interleukin 12 receptor beta2; human; pembrolizumab |
| Journal Title: | Seminars in Thoracic and Cardiovascular Surgery |
| Volume: | 29 |
| Issue: | 3 |
| ISSN: | 1043-0679 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | 416 |
| End Page: | 417 |
| Language: | English |
| DOI: | 10.1053/j.semtcvs.2017.08.014 |
| PROVIDER: | scopus |
| PUBMED: | 28967537 |
| DOI/URL: | |
| Notes: | Editorial -- Export Date: 2 January 2018 -- Source: Scopus |
